Sarasota, FL, Oct. 27, 2016 -- Zion Research has published a new report titled “Vascular Stents Market (Fem-Pop Artery Stents, Iliac Artery Stents, Renal Artery Stents, Carotid Artery Stents, and Others): Global Industry Perspective, Comprehensive Analysis, Size, Share, Growth, Segment, Trends and Forecast, 2015 – 2021”. According to the report, global vascular stents market was valued at USD 2,907.1 million in 2015 and is expected to generate revenue of USD 4,230.0 million by end of 2021, growing at a CAGR of 6.5% between 2015 and 2021.
In terms of revenue, North America held the largest share of global vascular stents market and is expected to dominate the market over the next few years. This growth is mainly due to rise adoption rates of minimally invasive surgeries coupled with the presence of patient awareness and high healthcare expenditure levels. Increasing aging population has resulted in the steady increase in the number of patients requiring treatment for peripheral vascular lesions in the U.S. In terms of the revenue, the iliac artery stents segment held the highest share followed by fem-pop artery stents in 2015, in this region. Carotid artery stents are expected to witness the fastest growth in the coming years.
Browse through 8 Market Tables and 26 Figures spread over 87 Pages and in-depth TOC on “Global Vascular Stents Market: By Product, Type, Size, Share, Industry Trends, Growth, Segment and Forecast 2015-2021”.
Request free Sample of this Report @ https://www.zionmarketresearch.com/sample/vascular-stents-market
In terms of revenue, North America was followed by Europe in 2015. Europe was the second largest regional market increasing aging population. Moreover, the adoption of new technologies is expected to witness significant growth in the years to come. The Germany represents the largest vascular stent market in this region followed by France and the UK. The growth in the market is led by rising awareness for health and rapid expansion of the healthcare industry. Fem-pop artery stent was the second largest segment followed by renal artery stents in terms of revenue in Europe.
Asia Pacific is expected to be the fastest growing market in near future. Injectable drug delivery market has the huge opportunity in the emerging markets of Asia Pacific due to the increasing population, rising incidence rate of chronic diseases, coupled with the rising health awareness among people, especially in China and India. Asia Pacific accounted for more than 20% share of the total market in 2015 and is expected to witness the fastest growth in the near future.
Browse the full "Vascular Stents Market (Fem-Pop Artery Stents, Iliac Artery Stents, Renal Artery Stents, Carotid Artery Stents and Others): Global Industry Perspective, Comprehensive Analysis, Size, Share, Growth, Segment, Trends and Forecast, 2015 – 2021" report at https://www.zionmarketresearch.com/report/vascular-stents-market
The Middle East & Africa regional market is expected to witness moderate growth in the near future. The growth is attributed to rapid growth in aging population coupled with health care awareness regarding PAD disease. Latin America is another important regional market and is expected to experience significant growth over the forecast period. Increasing healthcare industry coupled with the adoption of new technology developed for vascular stents in Brazil is anticipated to fuel market growth in Latin America.
North America dominated the market with over 39% share of total revenue generated in 2015. Europe was another key regional market and is expected to show substantial growth within the forecast period. Rapid growth in aging population has driven a steady increase in the number of patients requiring treatment for peripheral vascular lesions in the U.S. Asia Pacific accounted more than 20% share of the total market in 2015 and is expected to witness the fastest growth in the near future due to increasing aging population coupled with rising health awareness.
Inquire more about this report @ https://www.zionmarketresearch.com/inquiry/vascular-stents-market
Major market players for vascular stents include: Cordis Corporation (U.S.), Boston Scientific Corporation (U.S.), C.R. Bard, Inc. (U.S.), Cook Medical (U.S.) and W.L. Gore & Associates (U.S.) and Abbott Vascular, Inc. (U.S.)
Request a customize report @ https://www.zionmarketresearch.com/custom/284
This report segments the vascular stents market as follows:
Vascular Stents Market: Product Segment Analysis
- Fem-pop artery stents
- Iliac artery stents
- Renal artery stents
- Carotid artery stents
- Others
Vascular Stents Market: Regional Segment Analysis
- North America
- Europe
- Asia Pacific
- Latin America
- The Middle East & Africa
More Related Reports:
- Anti-Aging Market: https://www.zionmarketresearch.com/report/anti-aging-market
- Peripheral Guidewire Market: https://www.zionmarketresearch.com/report/peripheral-guidewire-market
- Fracture Fixation Product Market: https://www.zionmarketresearch.com/report/fracture-fixation-products-market
- Pain Management Devices Market: https://www.zionmarketresearch.com/report/pain-management-devices-market
- Reprocessed Medical Devices Market: https://www.zionmarketresearch.com/report/reprocessed-medical-devices-market
- Injectable Drug Delivery Market: https://www.zionmarketresearch.com/report/injectable-drug-delivery-market
About Us:
Zion Market Research is an obligated company. We create futuristic, cutting edge, informative reports ranging from industry reports, the company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.
Follow Us LinkedIn: https://www.linkedin.com/company/zion-market-research
Follow Us Twitter: https://twitter.com/zion_research
Contact Us: Joel John 4283, Express Lane, Suite 634-143, Sarasota, Florida 34249, United States Tel: +49-322 210 92714 USA/Canada Toll-Free No.1-855-465-4651 Email: [email protected] Website: https://www.zionmarketresearch.com/


Elliott Management Takes $1 Billion Stake in Lululemon, Pushes for Leadership Change
Dina Powell McCormick Resigns From Meta Board After Eight Months, May Take Advisory Role
7-Eleven CEO Joe DePinto to Retire After Two Decades at the Helm
Apple Opens iPhone to Alternative App Stores in Japan Under New Competition Law
Citi Appoints Ryan Ellis as Head of Markets Sales for Australia and New Zealand
LG Energy Solution Shares Slide After Ford Cancels EV Battery Supply Deal
Union-Aligned Investors Question Amazon, Walmart and Alphabet on Trump Immigration Policies
Toyota to Sell U.S.-Made Camry, Highlander, and Tundra in Japan From 2026 to Ease Trade Tensions
Oracle Stock Slides After Blue Owl Exit Report, Company Says Michigan Data Center Talks Remain on Track
Volaris and Viva Agree to Merge, Creating Mexico’s Largest Low-Cost Airline Group
Delta Air Lines President Glen Hauenstein to Retire, Leaving Legacy of Premium Strategy
Roche CEO Warns US Drug Price Deals Could Raise Costs of New Medicines in Switzerland
Bridgewater Associates Plans Major Employee Ownership Expansion in Milestone Year
Instacart Stock Drops After FTC Probes AI-Based Price Discrimination Claims
Trump Signals Push for Lower Health Insurance Prices as ACA Premium Concerns Grow
Nike Shares Slide as Margins Fall Again Amid China Slump and Costly Turnaround
Elon Musk Wins Reinstatement of Historic Tesla Pay Package After Delaware Supreme Court Ruling 



